World

Charles River Laboratories Acquires SAMDI Tech

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired SAMDI Tech, Inc, a leading provider of high-quality, l...

 January 31, 2023 | News

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering

Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights. Expands o...

 January 31, 2023 | News

Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28

Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb....

 January 31, 2023 | News

Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an Investigational Respiratory Syncytial Virus (Rsv) Vaccine Candidate

 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investig...

 January 30, 2023 | News

Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso

As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-...

 January 24, 2023 | News

New Eppendorf Conical Tubes 25 mL variants for even better sample recovery

The innovative material of the amber-colored Conical Tubes 25 mL is highly transparent, while at the same time effectively protecting the sample from low-w...

 January 24, 2023 | News

Ingenovis Health Announces New Webinar Series for Clinicians

Top healthcare talent and workforce provider, Ingenovis Health (Ingenovis), is launching a new webinar series for clinicians. The ACT Webinar Series for He...

 January 23, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

 January 23, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

 January 23, 2023 | News

Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolutio...

 January 23, 2023 | News

Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1

Data derived from the test can help to serve as a critical tool to monitor and help treat HIV-1-infected individuals, as well as inform epidemiologic and g...

 January 23, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

 January 23, 2023 | News

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the c...

 January 23, 2023 | News

CureSearch To Lead Impact Study On Cost, Treatment Benefits Of Molecular Testing For Childhood Cancer Patients

Cancer is the number one disease killer in children in the US. Although survival rates for the most common types of childhood cancer have greatly increased...

 January 20, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close